Journal articles on the topic 'ASCOE'

To see the other types of publications on this topic, follow the link: ASCOE.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'ASCOE.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Amarenco, P., J. Bogousslavsky, L. R. Caplan, G. A. Donnan, M. E. Wolf, and M. G. Hennerici. "The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping)." Cerebrovascular Diseases 36, no. 1 (2013): 1–5. http://dx.doi.org/10.1159/000352050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ljubec, Živa. "The myth of ASCOT and its rival ASCO2.T: Tech-noetic vs. techno-logic, round 1." Technoetic Arts 9, no. 2 (May 17, 2012): 89–96. http://dx.doi.org/10.1386/tear.9.2-3.89_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rotar, O. P. "Evidence born from ASCOT trial – still important after 15 years." Eurasian heart journal, no. 3 (September 27, 2021): 46–53. http://dx.doi.org/10.38109/2225-1685-2021-3-46-53.

Full text
Abstract:
The paper presents the overview evolution of hypertension identification and treatment during last 15 years after publication of ASCOT trial (AngloScandinavian Cardiac Outcomes Trial) results. It discusses possible mechanism of more significant cardiovascular risk reduction in amlodipine/ perindopril group comparing with atenolol/diuretic group: central blood pressure, arterial stiffness, asleep blood pressure and BP variability. Innovative approaches in time of ASCOТ trial such as combined antihypertensive therapy from start and RAAS inhibitor as first line now became routine practice in actual guidelines. Importance of early prescribing of fixed antihypertensive combination and choice of safe drugs help to improve adherence and decrease resistant hypertension prevalence. Prevention of new onset of diabetes in metabolic patients needs application of metabolically neutral drugs and including of renin-angiotensin-aldosterone inhibitors in combination therapy. Results of ASCOT-Legacy trial demonstrated long-term protective effect of amlodipine/perindopril combination resulting in decreasing mortality, rate of stroke and coronary events during 20-years follow-up.
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Hung-Hsuan, and C. Lee Giles. "ASCOS++." ACM Transactions on Knowledge Discovery from Data 10, no. 2 (October 26, 2015): 1–26. http://dx.doi.org/10.1145/2776894.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Murphy, Matthew P., Christina Buckley, Conor Sugrue, Emma Carr, Aine O’Reilly, Shane O’Neill, and Sean M. Carroll. "ASCOT." Plastic and Reconstructive Surgery - Global Open 5, no. 9 (September 2017): e1486. http://dx.doi.org/10.1097/gox.0000000000001486.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ljubec, Živa. "The uncertainty of ASCOT and the second-order hesitation of ASCO2.T within the transdisciplinary buffer zone, Round 2." Technoetic Arts 11, no. 2 (September 1, 2013): 149–61. http://dx.doi.org/10.1386/tear.11.2.149_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Klein, Friederike, and Sandrina Bachmaier. "++ Ticker ++ ASCO 2020 ++ Ticker ++ ASCO 2020 ++ Ticker ++ ASCO 2020 ++ Ticker ++ ASCO 2020 ++." Im Fokus Onkologie 23, no. 4 (September 2020): 87. http://dx.doi.org/10.1007/s15015-020-2552-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Szyndler, Anna. "Spuścizna badania ASCOT — obserwacja odległa ASCOT-Legacy." Choroby Serca i Naczyń 16, no. 2 (June 27, 2019): 112–15. http://dx.doi.org/10.5603/chsin.2019.0016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fuchs, Flávio Danni, Miguel Gus, and Jorge Pinto Ribeiro. "ASCOT-BPLA." Lancet 367, no. 9506 (January 2006): 205. http://dx.doi.org/10.1016/s0140-6736(06)68022-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Donzelli, Alberto, and Alberto Malliani. "ASCOT-BPLA." Lancet 367, no. 9506 (January 2006): 205–6. http://dx.doi.org/10.1016/s0140-6736(06)68023-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Goldstein, Mark R. "ASCOT-BPLA." Lancet 367, no. 9506 (January 2006): 206. http://dx.doi.org/10.1016/s0140-6736(06)68024-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Duerden, Martin. "ASCOT-BPLA." Lancet 367, no. 9506 (January 2006): 206. http://dx.doi.org/10.1016/s0140-6736(06)68025-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Ostroumova, O. D., and O. V. Bondarets. "«Rozhdennyy» ASCOT." Systemic Hypertension 8, no. 2 (June 15, 2011): 10–17. http://dx.doi.org/10.26442/sg28907.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Butcher, Lola. "ASCO." Oncology Times 34, no. 6 (March 2012): 10–11. http://dx.doi.org/10.1097/01.cot.0000413557.07401.2b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Butcher, Lola. "ASCO." Oncology Times 37, no. 22 (November 2015): 22–23. http://dx.doi.org/10.1097/01.cot.0000475236.68696.5b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Liebson, Philip R. "ASCOT-Blood Pressure Trial (ASCOT-BPLA) and HOPE-TOO." Preventive Cardiology 9, no. 1 (January 2006): 60–63. http://dx.doi.org/10.1111/j.1520-037x.2006.4991.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Lazar, Ross Allen. "Phönix aus der Asche – oder Asche auf unser Haupt?" Forum der Psychoanalyse 32, no. 4 (October 27, 2016): 335–58. http://dx.doi.org/10.1007/s00451-016-0251-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Prieto-Merino, D., J. Dobson, A. K. Gupta, C.-L. Chang, P. S. Sever, B. Dahlöf, H. Wedel, S. Pocock, and N. Poulter. "ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data." Journal of Human Hypertension 27, no. 8 (February 14, 2013): 492–96. http://dx.doi.org/10.1038/jhh.2013.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Al-Taher, Hanna, and Matthias Ebenaus. "Phoenix und Asche." PROKLA. Zeitschrift für kritische Sozialwissenschaft 39, no. 157 (December 1, 2009): 645–62. http://dx.doi.org/10.32387/prokla.v39i157.416.

Full text
Abstract:
Against the backdrop of the Global Economic Crisis India's neoliberal elites initially argued, that its economy was safely decoupled from that of western countries, giving way to the fashionable 'decoupling theory': The evolving debate centered on whether or not, and later on how, India would be affected by the global crisis, but failed to recognize that any analysis attempting to grasp the current development fully, must not only connect the crisis to the economic development preceding it but also consider effects beyond the economy's internationalized sectors. We argue that while the economic crisis does affect India's internationalized economic segments adversely, particularly via the channels of foreign trade, international capital flows and availability of credit, the majority of the Indian population suffers from social crises, rooted in the country's economic strategy and expressed through agricultural distress combined with precarious employment conditions, which have persisted for much longer than the current global crisis. The majority of the population which suffered from 'Incredible India's' 'predatory growth' will have to carry the burden of its economic recovery and continued pursuit of the status of a major economic power.
APA, Harvard, Vancouver, ISO, and other styles
20

Moser, Marvin. "The ASCOT Trial." Journal of Clinical Hypertension 7, no. 12 (December 2005): 748–50. http://dx.doi.org/10.1111/j.1524-6175.2005.05298.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Meurin, Philippe. "The ASCOT Trial." American Journal of Cardiovascular Drugs 6, no. 5 (2006): 327–34. http://dx.doi.org/10.2165/00129784-200606050-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Vij, Ravi. "ASCO 2017." Oncology Times 39, no. 14 (July 2017): 11. http://dx.doi.org/10.1097/01.cot.0000521873.07556.7b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kahl, Brad. "ASCO 2017." Oncology Times 39, no. 14 (July 2017): 15. http://dx.doi.org/10.1097/01.cot.0000521876.30427.09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Varadhachary, Gauri R. "ASCO 2017." Oncology Times 39, no. 15 (August 2017): 1. http://dx.doi.org/10.1097/01.cot.0000524337.34983.fc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Stadler, Walter. "ASCO 2017." Oncology Times 39, no. 15 (August 2017): 16. http://dx.doi.org/10.1097/01.cot.0000524341.57854.ac.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Rouëssé, J., and M. Spielmann. "ASCO 2006." Oncologie 8, no. 7 (August 2006): 627. http://dx.doi.org/10.1007/s10269-006-0474-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

&NA;. "ASCO Awards." Oncology Times 31, Sup 1 (August 2009): 13–14. http://dx.doi.org/10.1097/01.cot.0000359116.82554.6b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Aparicio, T. "ASCO 2014." Côlon & Rectum 8, no. 3 (July 18, 2014): 186–89. http://dx.doi.org/10.1007/s11725-014-0540-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Rosenthal, Eric T. "ASCO ʼ07." Oncology Times 29, no. 10 (May 2007): 14–15. http://dx.doi.org/10.1097/01.cot.0000282460.24414.98.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Lindsey, Heather. "ASCO Forum." Oncology Times 29, no. 14 (July 2007): 7–11. http://dx.doi.org/10.1097/01.cot.0000285388.64776.98.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Antoline, Dawn. "ASCO 05." Oncology Times 27, no. 9 (May 2005): 3–4. http://dx.doi.org/10.1097/01.cot.0000289234.32733.de.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Nalley, Catlin. "ASCO 2018." Oncology Times 40, no. 10 (May 2018): 1. http://dx.doi.org/10.1097/01.cot.0000534128.64904.98.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Stadler, Walter. "ASCO 2012." Oncology Times 34, no. 13 (July 2012): 14–16. http://dx.doi.org/10.1097/01.cot.0000416573.94761.b8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Khuri, Fadlo R. "ASCO 2012." Oncology Times 34, no. 14 (July 2012): 18–20. http://dx.doi.org/10.1097/01.cot.0000418361.62055.9e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Camidge, D. Ross. "ASCO 2013." Oncology Times 35, no. 15 (August 2013): 8. http://dx.doi.org/10.1097/01.cot.0000433544.84248.f6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Rosenthal, Eric T. "ASCO Survey." Oncology Times 36, no. 8 (April 2014): 1. http://dx.doi.org/10.1097/01.cot.0000446652.05209.e7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Vij, Ravi. "ASCO 2016." Oncology Times 38, no. 14 (July 2016): 1. http://dx.doi.org/10.1097/01.cot.0000490049.97840.0f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Stinchcombe, Tom. "ASCO 2016." Oncology Times 38, no. 15 (August 2016): 13. http://dx.doi.org/10.1097/01.cot.0000491025.14152.bd.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

MA, Cynthia X. "ASCO 2016." Oncology Times 38, no. 15 (August 2016): 14–16. http://dx.doi.org/10.1097/01.cot.0000491026.08314.64.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Marshall, John L. "ASCO 2016." Oncology Times 38, no. 15 (August 2016): 20–21. http://dx.doi.org/10.1097/01.cot.0000491028.93066.98.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Morgensztern, Daniel. "ASCO 2016." Oncology Times 38, no. 16 (August 2016): 1. http://dx.doi.org/10.1097/01.cot.0000494616.81252.f5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Pachynski, Russell K. "ASCO 2016." Oncology Times 38, no. 16 (August 2016): 24. http://dx.doi.org/10.1097/01.cot.0000494621.11747.fc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Nalley, Catlin. "ASCO 2017." Oncology Times 39, no. 10 (May 2017): 1. http://dx.doi.org/10.1097/01.cot.0000520156.98965.ff.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Bartsch, Rupert, Veronique Dieras, Javier Cortes, Volkmar Müller, and Thomas Ruhstaller. "ASCO 2020." Breast Care 15, no. 4 (2020): 433–36. http://dx.doi.org/10.1159/000510051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Aparicio, T. "ASCO 2012." Côlon & Rectum 6, no. 3 (August 2012): 210–11. http://dx.doi.org/10.1007/s11725-012-0396-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Aparicio, T., E. François, and E. Mitry. "ASCO 2013." Côlon & Rectum 7, no. 3 (June 27, 2013): 190–92. http://dx.doi.org/10.1007/s11725-013-0460-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Junker, Annette. "ASCO 2003." Der Onkologe 9, no. 8 (August 1, 2003): 894–900. http://dx.doi.org/10.1007/s00761-003-0553-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Junker, A. "ASCO 2006." Der Onkologe 12, no. 9 (September 2006): 934–41. http://dx.doi.org/10.1007/s00761-006-1104-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Junker, A., and A. Gaisser. "ASCO 2008." Der Onkologe 14, no. 10 (August 29, 2008): 1079–84. http://dx.doi.org/10.1007/s00761-008-1440-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Junker, A. "ASCO 2013." Der Onkologe 19, no. 10 (September 4, 2013): 887–92. http://dx.doi.org/10.1007/s00761-013-2548-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography